期刊档案 · 医学-内分泌学与代谢
Acta Diabetologica
ISSN 0940-5429 · eISSN 1432-5233 · Springer Milan · ITALY · Quarterly · 创刊 1964
Acta Diabetologica 中科院 医学 3区（2025 年升级版），影响因子 3.11，混合开放获取，APC 约 4,590 美元，近 24 个月 97 篇文章投稿到接收中位 88 天，录用比例约50%（社区反馈），2025 年发文 189 篇，SCIE、Scopus 收录。
研究范围
研究范围与定位
Acta Diabetologica 由 Springer Milan 出版，属中科院医学大类（2025 升级版3区）。按 OpenAlex 近年发文统计，该刊主要发表 Diabetes Management and Research、Diabetes and associated disorders、Pancreatic function and diabetes 等主题的论文，这 3 个主题约占 34.7%，主导子领域为 Endocrinology, Diabetes and Metabolism。（根据 OpenAlex 主题统计与中科院分区数据生成）
Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica. Manuscripts submitted for publication must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted. Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 86-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable. The Editor-in-chief reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements. The journal is open for publication of supplements and for publishing abstract s of scientific meetings. Condition can be obtained from the Editor-in Chief or the publisher. Founding Editor G Pozza, Milan (Italy) Honorary Editor R Lauro, Rome (Italy)
摘自期刊官网 Aims & Scope
研究方向（LetPub）：医学-内分泌学与代谢
主编 Massimo Federici出版商官网
编委会国家分布：未见中国大陆编委；主要国家 意大利 25、美国 2、德国 1、澳大利亚 1、比利时 1（共 32 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Diabetes Management and ResearchMedicine13.3%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology11.2%
- Pancreatic function and diabetesMedicine10.2%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine7.9%
- Diabetes Treatment and ManagementMedicine7.8%
- Metabolism, Diabetes, and CancerBiochemistry, Genetics and Molecular Biology5.1%
- Diet and metabolism studiesMedicine4.2%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine4%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 内分泌学与代谢ENDOCRINOLOGY & METABOLISM | 3 区 |
Top 期刊：否综述期刊：否
《新锐期刊分区表》（ 2026年3月发布）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 内分泌学与代谢ENDOCRINOLOGY & METABOLISM | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）医学 3 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 3 区 |
| 小类 | 内分泌学与代谢ENDOCRINOLOGY & METABOLISM | 3 区 |
Top 期刊：否综述期刊：否
数据库收录
SCIEScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
期刊官网自述收录
MEDLINEEmbaseCASCAB AbstractsCurrent Contents出版商官网
其他：Google Scholar、EBSCO、ProQuest、Dimensions、CNKI、Baidu、Naver、OCLC、Portico、CLOCKSS、Semantic Scholar
期刊官网列出的收录清单，未与各数据库逐一核对；Web of Science 各子库以上方记录为准。
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子
- 3.11LetPub ·
- 影响因子（出版商公布） 2025
- 3.1出版商官网 ·
- 五年影响因子（出版商公布） 2025
- 3.2出版商官网 ·
- CiteScore 2026-06
- 5.7LetPub ·
- SJR 2026-06
- 1.01LetPub ·
- SNIP 2026-06
- 1.01LetPub ·
- h-index
- 56LetPub ·
- h-index
- 108OpenAlex ·
- i10-index
- 2,127OpenAlex ·
- 两年平均被引
- 3OpenAlex ·
- 自引率
- 3.2%LetPub ·
- Gold OA 文章占比
- 34.02%LetPub ·
发文规模
- 年文章数
- 169LetPub ·
- 年下载量（出版商公布） 2025
- 870,100出版商官网 ·
逐年发文量 OpenAlex 统计 · 累计 4,993 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 168 | 61 | 48 |
| 2025 | 189 | 64 | 552 |
| 2024 | 211 | 80 | 1,106 |
| 2023 | 198 | 91 | 1,964 |
| 2022 | 190 | 98 | 2,377 |
| 2021 | 188 | 103 | 3,793 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
文章统计的审稿周期 Crossref 登记的稿件日期 · 至
88 天投稿到接收中位数 · P25–P75 60 天 – 128 天
- 接收到上线
- 中位数 26 天（98 篇）
- 投稿到上线
- 中位数 124 天
- 样本
- 97 篇有投稿与接收日期的文章（窗口内共 414 篇），最近一篇接收于
只统计最终被录用并发表的文章，不含被拒稿件的处理时间，因此通常长于出版商公布的"首次决定时间"。
其他来源
- 平均审稿速度（社区反馈）
- 平均2月LetPub ·
- 平均录用比例（社区反馈）
- 50%LetPub ·
- 投稿到首次决定
- 8 天出版商官网 ·
- 评审方式
- 双盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 4,590 / EUR 3,590 / GBP 2,890 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点4 项，摘自作者指南
- 摘要
- 150–250 词
- 关键词
- ≥ 4 个
- 参考文献格式
- 顺序编码制（按引用顺序编号）
- 推荐审稿人
- 可选
接收的文章类型13 种，含篇幅限制
- case reporton. Up to 45 references are permitted.. Case reports They must not exceed 2,000 words, 5 references and 5 authors. They should not have an abstra正文 ≤ 2,000 词
- case reportsThey must not exceed 2,000 words, 5 references and 5 authors. They should not have an abstract, not include more than 2 illustrations.未说明篇幅
- editorialIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…未说明篇幅
- editorialsEditorials are usually written by members of the Editorial and Advisory Board. They should not exceed 500 words, not include more than 1 illustration and refere…未说明篇幅
- letters to the editorsLetters to the editors must not exceed 600 words (and 5 references) with one table or figure and without abstracts. They should be addressed to the Editors-in-C…未说明篇幅
- meta-analysisIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…未说明篇幅
- original papersOriginal papers should have a structured abstract (Aims, Methods, Results and Conclusions), must not exceed 3,000 words and should not include more than 6 illus…未说明篇幅
- position statementA position statement is written by experts on a specific topic of interest in the clinical practice of diabetes and associated disorders.未说明篇幅
- reviewIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…未说明篇幅
- review articleIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…未说明篇幅
- short communicationnot include more than 2 illustrations. Short communications They must not exceed 1,000 words, should not have an abstract. They should not exceed 1,000正文 ≤ 1,000 词
- short communicationsThey must not exceed 1,000 words, should not have an abstract. They should not exceed 1,000 words; 2 illustrations and up to 5 references are permitted.未说明篇幅
- systematic reviewIt is the policy of Acta Diabetologica to ensure balance, independence, objectivity and scientific rigor in the journal. All authors are expected to disclose to…未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、试验注册 / 报告规范
- AI 使用 Generative AI Images
请查看Springer关于生成式AI图像的政策，并确保您的工作符合其中所述的原则。 模型中文摘要
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
原文 ↗出版商官网 ·- 作者资格 Authorship principles
期刊和出版商假定所有作者同意稿件内容、均明确同意投稿，并已在投稿前获得开展该工作的机构/组织中负责当局的同意；出版商不规定何种贡献可构成作者身份，建议作者遵循适用的作者身份指南。 模型中文摘要
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
原文 ↗出版商官网 ·- 利益冲突 Conflict of interest
作者必须说明其与研究资助机构之间是否存在财务关系，该说明应放在参考文献列表之前的单独部分；如无利益冲突，应声明“作者声明不存在利益冲突”。 模型中文摘要
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. This note should be added in a separate section before the reference list. If no conflict exists, authors should state: The authors declare that they have no conflict of interest. Back to top
原文 ↗出版商官网 ·- 数据可用性 Data availability
期刊鼓励作者在文章中提供数据可用性声明，说明支持文章结果的数据可在何处获取（如适用，包括公开存档数据集的链接），也可说明数据可应请求提供或无数据可用。 模型中文摘要
The journal encourages authors to provide a statement of Data availability in their article. Data availability statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether data are av…
原文 ↗出版商官网 ·- 出版伦理 Ethical standards
投稿稿件必须声明所有人类和动物研究均已获得相应伦理委员会批准，并按照1964年《赫尔辛基宣言》及其后续修订版规定的伦理标准进行；文中还应明确说明所有受试者在纳入研究前均已获得知情同意，并应省略可能透露受试者身份的细节。 模型中文摘要
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed conse…
原文 ↗出版商官网 ·- 许可与版权 Copyright
Open Choice文章无需转让版权，版权仍归作者所有；选择开放获取即表示作者同意在知识共享许可下发表文章，具体许可详情见期刊网站的“如何与我们一起出版”指南。 模型中文摘要
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
原文 ↗出版商官网 ·- 开放获取 Open access publishing
欲了解在《Acta Diabetologica》开放获取发表的相关信息（包括费用、资助和许可），请访问期刊的开放获取出版页面。 模型中文摘要
To find out more about publishing your work Open Access in Acta Diabetologica, including information on fees, funding and licences, visit our Open access publishing page. Back to top
原文 ↗出版商官网 ·- 同行评审
作者在投稿时可以推荐合适的审稿人和/或要求排除某些个人。 模型中文摘要
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
原文 ↗出版商官网 ·- 试验注册 / 报告规范 Clinical Trial Registration
世界卫生组织将临床试验定义为“任何前瞻性地将人类受试者或人群分配至一项或多项健康相关干预措施，以评估健康结局效果的研究”。 模型中文摘要
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Springer Milan
- 出版国家或地区
- ITALY
- 出版语言
- English
- 出版周期
- Quarterly
- 创刊年份
- 1964
- ISSN
- 0940-5429
- 电子版 ISSN
- 1432-5233
- 官网最新一期
- Volume 63, Issue 9（2026 年 9 月）
- 官方链接
- 期刊主页 ↗OpenAlex
- 投稿系统 ↗LetPub
- 作者指南 ↗LetPub
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Acta Diabetologica 的常见问题
Acta Diabetologica 是中科院几区期刊？
2025 年升级版分区表中，Acta Diabetologica 为医学 3区，小类 内分泌学与代谢 3 区。2026 年新锐版分区表中为医学 3区。不同版本与大小类分区不能混用。
Acta Diabetologica 的影响因子是多少？
LetPub 汇总的最新公布影响因子为 3.11，CiteScore 为 5.7，h-index 为 108。
Acta Diabetologica 的审稿周期多长？
按 2024年10月至2026年10月（近 24 个月）97 篇已发表文章登记的日期，投稿到接收的中位数为 88 天（四分位 60–128 天）；投稿社区反馈的平均审稿速度为约 2 个月，平均录用比例反馈为“约50%”。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Acta Diabetologica 的投稿格式要求是什么？
据期刊作者指南：摘要：150–250 词；关键词：≥ 4 个；参考文献格式：顺序编码制（按引用顺序编号）；推荐审稿人：可选。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Acta Diabetologica 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 32 位编委中，没有中国大陆学者；人数最多的国家是 意大利（25 位）、美国（2 位）、德国（1 位）。统计按编委会页面列出的机构国家计，仅供参考。
Acta Diabetologica 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Acta Diabetologica 被 SCIE、Scopus 收录。期刊官网自述还被 MEDLINE、Embase、CAS、CAB Abstracts、Current Contents 收录，该清单未与各数据库逐一核对。
Acta Diabetologica 是开放获取期刊吗？版面费多少？
Acta Diabetologica 为混合开放获取。选择开放获取发表时APC 约 4,590 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-24 归档）。最近更新：。